Olovidm Eye Drops 0.1% (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Mothers Pharmaceutical Co., Ltd.
MFDS item code 201905881 · Approved 2019.08.20
This product's status changed to Expired on 2024.08.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Relief of symptoms associated with allergic conjunctivitis.
Used to relieve symptoms such as itching, redness, tearing, and swelling of the eyes caused by allergic conjunctivitis.
Instill 1 drop twice a day (at intervals of 6 to 8 hours). Treatment may continue for a maximum of 4 months if needed.
This medication should not be used by patients who are allergic to the active ingredient or any component of this medication. While using this medication, headaches or altered taste may occur, and dizziness may also rarely appear. Symptoms such as punctate keratitis, keratitis, eye pain, dryness, swelling, itching, discharge, redness, eyelid keratinization, and discomfort may develop. Also, symptoms such as glare, blurred vision, and eyelid redness have been reported infrequently. Dry nose, rhinitis, dry mouth, contact dermatitis, and fatigue may also rarely occur. Some patients may experience increased sensitivity of the eyes, weakness, cold symptoms, nausea, pharyngitis, sinusitis, skin rash, abdominal pain, liver dysfunction, jaundice, increased blood pressure, leukopenia and lymphopenia, elevated blood test results, and urinary difficulties. The phosphate component included in this medication may very rarely cause calcareous degeneration of the cornea in patients with severe corneal damage, so caution is warranted. Blurry vision can temporarily occur after instillation, so patients should wait until their vision is clear before driving or operating machinery. Patients who are on long-term steroid treatment should gradually reduce the steroid dosage under the supervision of a doctor while using this medication. Patients with seasonal allergies should start using this medication before the symptoms worsen and continue its use during the symptom period. If no effect is observed, it is advisable not to use this medication for a long time. The benzalkonium chloride component included in this medication may cause eye irritation and discoloration of contact lenses, so it should not be used while wearing contact lenses. Contact lenses should be worn only at least 15 minutes after instillation, and wearing contact lenses should be avoided when the eyes are red. During pregnancy, there have been reports of some side effects in animal experiments, so it should be used cautiously under the guidance of a doctor, and during breastfeeding, its effects on the baby should also be considered. The safety and efficacy of this medication have not been established for children under 3 years old, so its use should be avoided. Elderly patients do not require special dosage adjustments. In case of overdose, appropriate monitoring and management are necessary, and since this medication is an eye drop for ocular use only, it should not be used as an injection or oral medication. To prevent contamination during use, care should be taken not to let the tip of the container touch the eye directly, and the container must be closed tightly after use. When using other eye drops, a minimum interval of 5 minutes should be observed, and when using eye ointments, it is advisable to administer them last. This medication should be kept out of the reach of children, stored in a cool place away from direct sunlight.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that can block light and kept at room temperature between 4 and 25 degrees Celsius. Storing it this way will help maintain the efficacy of the medication for a longer time.
A colorless to pale yellow solution contained in an opaque white plastic bottle, formulated as eye drops.
For domestic use - 5mL - 5 milliliters/bottle, For domestic use - 6mL - 6 milliliters/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Mothers Pharmaceutical Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.